• Health & Medicine

Behind the scenes with the unsung heroes of cancer clinical trials – Part 1

We speak to Cindy Billingham, lead statistician on the National Lung Matrix Trial, about what her job involves. We speak to Cindy Billingham, lead statistician on the National Lung Matrix Trial, about what her job involves.

20 May 2017

• Health & Medicine

Targeted drug delays relapse of intermediate-stage lung cancer

A drug holds lung cancer at bay longer after surgery than standard chemotherapy, according to unpublished results of a new trial in China. A drug holds lung cancer at bay longer after surgery than standard chemotherapy, according to unpublished results of a new trial in China.

19 May 2017

• Health & Medicine

Experimental blood test could offer a glimpse of the future for doctors treating lung cancer

An experimental blood test could offer a way to detect early signs that patients’ lung cancers will return after treatment. An experimental blood test could offer a way to detect early signs that patients’ lung cancers will return after treatment.

26 April 2017

• Science & Technology

Tracing genetic chaos in 100 lung cancer patients could help predict survival

By tracing genetic chaos over time our scientists may have found a way to help predict lung cancer survival. By tracing genetic chaos over time our scientists may have found a way to help predict lung cancer survival.

26 April 2017

• Science & Technology
• Health & Medicine

Tracking unstable chromosomes helps predict lung cancer’s return

The first findings from the Cancer Research UK-funded TRACERx* lung cancer study show how tracking tumour evolution can help predict relapse. The first findings from the Cancer Research UK-funded TRACERx* lung cancer study show how tracking tumour evolution can help predict relapse.

26 April 2017

• Health & Medicine

Long term benefits of immunotherapy emerging for some patients, though key questions remain

A number of cancer clinical trials involving immunotherapy treatments appear to be showing promise, according to new research. A number of cancer clinical trials involving immunotherapy treatments appear to be showing promise, according to new research.

10 April 2017

• Health & Medicine

Training viruses to be cancer killers

Our scientists at the Cancer Research UK Oxford Centre are developing a cancer-killing virus. Watch it working on their labs 'cell CCTV'. Our scientists at the Cancer Research UK Oxford Centre are developing a cancer-killing virus. Watch it working on their labs 'cell CCTV'.

21 March 2017

• Science & Technology

Targeting cancer cell suicide: a TRAIL of two faces

New research by our scientists may have found a way to target a faulty cell suicide pathway in cancer. New research by our scientists may have found a way to target a faulty cell suicide pathway in cancer.

9 March 2017

• Health & Medicine

Commuting and polluting – whose health is losing out?

We look at new research measuring how much pollution we're exposed to on our commutes, particularly in London. We look at new research measuring how much pollution we're exposed to on our commutes, particularly in London.

3 March 2017

• Health & Medicine

Combining statins with chemotherapy doesn’t extend survival in lung cancer

Taking cholesterol-lowering statins doesn’t benefit lung cancer patients when used alongside chemotherapy, according to new CRUK research. Taking cholesterol-lowering statins doesn’t benefit lung cancer patients when used alongside chemotherapy, according to new CRUK research.

3 March 2017

• Health & Medicine

Nose swab detects tobacco damage linked to lung cancer in smokers

A sample of cells taken from the inside of the nose could be used to indicate the damage caused to cells in the lung by smoking. A sample of cells taken from the inside of the nose could be used to indicate the damage caused to cells in the lung by smoking.

28 February 2017

• Science & Technology

Hitgen and Cancer Research UK’s Manchester Institute enter licence agreement in lung cancer

Cancer Research UK, Cancer Research Technology and HitGen Ltd have entered into a licence agreement to develop a novel class of drugs in lung cancer. Cancer Research UK, Cancer Research Technology and HitGen Ltd have entered into a licence agreement to develop a novel class of drugs in lung cancer.

28 February 2017